Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis

BACKGROUND: Advanced pancreatic cancer confers poor prognosis and treatment advancement has been slow. Recent randomized clinical trials (RCTs) have demonstrated survival benefits for combination therapy compared to gemcitabine alone. However, the comparative benefits and harms of available combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gresham, Gillian K, Wells, George A, Gill, Sharlene, Cameron, Christopher, Jonker, Derek J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097092/
https://www.ncbi.nlm.nih.gov/pubmed/24972449
http://dx.doi.org/10.1186/1471-2407-14-471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097092/
https://www.ncbi.nlm.nih.gov/pubmed/24972449
http://dx.doi.org/10.1186/1471-2407-14-471

Ejemplares similares